Literature DB >> 23408434

Neuronatin-mediated aberrant calcium signaling and endoplasmic reticulum stress underlie neuropathology in Lafora disease.

Jaiprakash Sharma1, Diptendu Mukherjee, Sudheendra N R Rao, Soumya Iyengar, Susarla Krishna Shankar, Parthasarathy Satishchandra, Nihar Ranjan Jana.   

Abstract

Lafora disease (LD) is a teenage-onset inherited progressive myoclonus epilepsy characterized by the accumulations of intracellular inclusions called Lafora bodies and caused by mutations in protein phosphatase laforin or ubiquitin ligase malin. But how the loss of function of either laforin or malin causes disease pathogenesis is poorly understood. Recently, neuronatin was identified as a novel substrate of malin that regulates glycogen synthesis. Here we demonstrate that the level of neuronatin is significantly up-regulated in the skin biopsy sample of LD patients having mutations in both malin and laforin. Neuronatin is highly expressed in human fetal brain with gradual decrease in expression in developing and adult brain. However, in adult brain, neuronatin is predominantly expressed in parvalbumin-positive GABAergic interneurons and localized in their processes. The level of neuronatin is increased and accumulated as insoluble aggregates in the cortical area of LD brain biopsy samples, and there is also a dramatic loss of parvalbumin-positive GABAergic interneurons. Ectopic expression of neuronatin in cultured neuronal cells results in increased intracellular Ca(2+), endoplasmic reticulum stress, proteasomal dysfunction, and cell death that can be partially rescued by malin. These findings suggest that the neuronatin-induced aberrant Ca(2+) signaling and endoplasmic reticulum stress might underlie LD pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23408434      PMCID: PMC3611017          DOI: 10.1074/jbc.M112.416180

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  Genetic depletion of the malin E3 ubiquitin ligase in mice leads to lafora bodies and the accumulation of insoluble laforin.

Authors:  Anna A DePaoli-Roach; Vincent S Tagliabracci; Dyann M Segvich; Catalina M Meyer; Jose M Irimia; Peter J Roach
Journal:  J Biol Chem       Date:  2010-06-10       Impact factor: 5.157

2.  The ubiquitin ligase E6-AP is induced and recruited to aggresomes in response to proteasome inhibition and may be involved in the ubiquitination of Hsp70-bound misfolded proteins.

Authors:  Amit Mishra; Swetha K Godavarthi; Megha Maheshwari; Anand Goswami; Nihar Ranjan Jana
Journal:  J Biol Chem       Date:  2009-02-20       Impact factor: 5.157

3.  Crucial roles of neuronatin in insulin secretion and high glucose-induced apoptosis in pancreatic beta-cells.

Authors:  Myung Kuk Joe; Hyo Jung Lee; Young Ho Suh; Kyu Lee Han; Joo Hyun Lim; Jihyun Song; Je Kyung Seong; Myeong Ho Jung
Journal:  Cell Signal       Date:  2008-01-18       Impact factor: 4.315

4.  Laforin, the most common protein mutated in Lafora disease, regulates autophagy.

Authors:  Carmen Aguado; Sovan Sarkar; Viktor I Korolchuk; Olga Criado; Santiago Vernia; Patricia Boya; Pascual Sanz; Santiago Rodríguez de Córdoba; Erwin Knecht; David C Rubinsztein
Journal:  Hum Mol Genet       Date:  2010-05-07       Impact factor: 6.150

5.  Regulation of glycogen synthesis by the laforin-malin complex is modulated by the AMP-activated protein kinase pathway.

Authors:  Maria Carmen Solaz-Fuster; José Vicente Gimeno-Alcañiz; Susana Ros; Maria Elena Fernandez-Sanchez; Belen Garcia-Fojeda; Olga Criado Garcia; David Vilchez; Jorge Dominguez; Mar Garcia-Rocha; Maribel Sanchez-Piris; Carmen Aguado; Erwin Knecht; Jose Serratosa; Joan Josep Guinovart; Pascual Sanz; Santiago Rodriguez de Córdoba
Journal:  Hum Mol Genet       Date:  2007-11-20       Impact factor: 6.150

Review 6.  Lafora progressive myoclonus epilepsy: a meta-analysis of reported mutations in the first decade following the discovery of the EPM2A and NHLRC1 genes.

Authors:  Shweta Singh; Subramaniam Ganesh
Journal:  Hum Mutat       Date:  2009-05       Impact factor: 4.878

7.  Co-chaperone CHIP stabilizes aggregate-prone malin, a ubiquitin ligase mutated in Lafora disease.

Authors:  Sudheendra N R Rao; Jaiprakash Sharma; Ranjan Maity; Nihar Ranjan Jana
Journal:  J Biol Chem       Date:  2009-11-05       Impact factor: 5.157

8.  The imprinted gene neuronatin is regulated by metabolic status and associated with obesity.

Authors:  Niels Vrang; David Meyre; Phillippe Froguel; Jacob Jelsing; Mads Tang-Christensen; Vincent Vatin; Jens D Mikkelsen; Kenneth Thirstrup; Leif K Larsen; Karina B Cullberg; Jan Fahrenkrug; Per Jacobson; Lars Sjöström; Lena M S Carlsson; Yongjun Liu; Xiaogang Liu; Hong-Wen Deng; Philip J Larsen
Journal:  Obesity (Silver Spring)       Date:  2009-10-22       Impact factor: 5.002

9.  The malin-laforin complex suppresses the cellular toxicity of misfolded proteins by promoting their degradation through the ubiquitin-proteasome system.

Authors:  Punitee Garyali; Pratibha Siwach; Pankaj Kumar Singh; Rajat Puri; Shuchi Mittal; Sonali Sengupta; Rashmi Parihar; Subramaniam Ganesh
Journal:  Hum Mol Genet       Date:  2008-11-25       Impact factor: 6.150

10.  Increased endoplasmic reticulum stress and decreased proteasomal function in lafora disease models lacking the phosphatase laforin.

Authors:  Santiago Vernia; Teresa Rubio; Miguel Heredia; Santiago Rodríguez de Córdoba; Pascual Sanz
Journal:  PLoS One       Date:  2009-06-16       Impact factor: 3.240

View more
  15 in total

Review 1.  [Lafora disease: a review of the literature].

Authors:  L Desdentado; R Espert; P Sanz; J Tirapu-Ustarroz
Journal:  Rev Neurol       Date:  2019-01-16       Impact factor: 0.870

2.  Neuronatin is a stress-responsive protein of rod photoreceptors.

Authors:  Vishal Shinde; Priyamvada M Pitale; Wayne Howse; Oleg Gorbatyuk; Marina Gorbatyuk
Journal:  Neuroscience       Date:  2016-04-21       Impact factor: 3.590

Review 3.  Lafora disease: from genotype to phenotype.

Authors:  Rashmi Parihar; Anupama Rai; Subramaniam Ganesh
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

4.  Altered expression of neuropeptides in FoxG1-null heterozygous mutant mice.

Authors:  Elisa Frullanti; Sonia Amabile; Maria Grazia Lolli; Anna Bartolini; Gabriella Livide; Elisa Landucci; Francesca Mari; Flora M Vaccarino; Francesca Ariani; Luca Massimino; Alessandra Renieri; Ilaria Meloni
Journal:  Eur J Hum Genet       Date:  2015-05-13       Impact factor: 4.246

5.  Characteristic Localization of Neuronatin in Rat Testis, Hair Follicle, Tongue, and Pancreas.

Authors:  Naoko Kanno; Saishu Yoshida; Takako Kato; Yukio Kato
Journal:  J Histochem Cytochem       Date:  2019-03-14       Impact factor: 2.479

6.  Identification of neural oscillations and epileptiform changes in human brain organoids.

Authors:  Ranmal A Samarasinghe; Osvaldo A Miranda; Jessie E Buth; Simon Mitchell; Isabella Ferando; Momoko Watanabe; Thomas F Allison; Arinnae Kurdian; Namie N Fotion; Michael J Gandal; Peyman Golshani; Kathrin Plath; William E Lowry; Jack M Parent; Istvan Mody; Bennett G Novitch
Journal:  Nat Neurosci       Date:  2021-08-23       Impact factor: 28.771

7.  Homeostasis of the astrocytic glutamate transporter GLT-1 is altered in mouse models of Lafora disease.

Authors:  Carmen Muñoz-Ballester; Arnaud Berthier; Rosa Viana; Pascual Sanz
Journal:  Biochim Biophys Acta       Date:  2016-03-11

8.  Trehalose Ameliorates Seizure Susceptibility in Lafora Disease Mouse Models by Suppressing Neuroinflammation and Endoplasmic Reticulum Stress.

Authors:  Priyanka Sinha; Bhupender Verma; Subramaniam Ganesh
Journal:  Mol Neurobiol       Date:  2020-10-22       Impact factor: 5.590

9.  SGK1 (glucose transport), dishevelled2 (wnt signaling), LC3/p62 (autophagy) and p53 (apoptosis) proteins are unaltered in Lafora disease.

Authors:  Peixiang Wang; Lori Israelian; Yunlin Xue; Siyuan Song; Liliana Attisano; Berge A Minassian
Journal:  All Results J Biol       Date:  2016

Review 10.  Lafora disease: Current biology and therapeutic approaches.

Authors:  S Mitra; E Gumusgoz; B A Minassian
Journal:  Rev Neurol (Paris)       Date:  2021-07-21       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.